KNOWLEDGE AND INNOVATION AT YOUR SERVICE
OUR TECHNOLOGY
PATENT AND PUBLICATIONS RELATED
Biosensor de Células Tumorales Circulantes, Patent Application No. MX/a/2017/010319.
Multifrequency Signal Processing Classifiers, U.S. Patent Application No. 61/810,665.
Detección Neoplasias Cancerígneas - Nanopartículas Magnéticas, Patent Application No. MX/E/2007/074511.
Electrical Bioimpedance Spectroscopy as Biosensor Technique to Identify Pluripotent Stem Cells and Fibroblasts. Int J cell Sci & mol biol. 2017; 3(2) : 555610.
Assessment of GRB2 Dynamics vs. Bioimpedance Measurements as a Function of Systemic Infusion of “Magnetic Nanoparticle - Anti-HER2” in an Experimental Breast Cancer Model. J Nanomed Res (2017) 5(2): 00107.
Assessment of the systemic distribution of a bioconjugated anti-Her2 magnetic nanoparticle in a breast cancer model by means of magnetic resonance imaging”. J Nanopart Res (2016) 18:284.
Fluorescent Bioconjugate Based on Gold Nanoparticles for the Determination of Staphylococcus aureus, Analytical Letters, (2016): 1862-1873
Characterization of Breast Cancer Radiofrequency Ablation Assisted with Magnetic Nanoparticles: In Silico and in Vitro Study. Journal of Electromagnetic Analysis and Applications, 8, 1-7 (2016).
Breast Cancer Tissue Marked Selectively by Magnetic Nanoparticles in an Experimental animal Model”. J. Nanoasci Nanotechnol. (2015),
c-erbB-2 as a Possible Target for the Use of Magnetic Nanoparticles in Breast Cancer Cells”. IEEE Transactions on NanoBioscience (2014), Volume:13, No 3, 300-307.
Impedance spectroscopy assisted by magnetic nanoparticles as a potential biosensor principle for breast cancer cells in suspension”. Physiol Meas (2014) 35 931–941.
Multifrequency Signal Processing Classifiers, U.S. Patent Application No. 61/810,665.
Detección Neoplasias Cancerígneas - Nanopartículas Magnéticas, Patent Application No. MX/E/2007/074511.
Electrical Bioimpedance Spectroscopy as Biosensor Technique to Identify Pluripotent Stem Cells and Fibroblasts. Int J cell Sci & mol biol. 2017; 3(2) : 555610.
Assessment of GRB2 Dynamics vs. Bioimpedance Measurements as a Function of Systemic Infusion of “Magnetic Nanoparticle - Anti-HER2” in an Experimental Breast Cancer Model. J Nanomed Res (2017) 5(2): 00107.
Assessment of the systemic distribution of a bioconjugated anti-Her2 magnetic nanoparticle in a breast cancer model by means of magnetic resonance imaging”. J Nanopart Res (2016) 18:284.
Fluorescent Bioconjugate Based on Gold Nanoparticles for the Determination of Staphylococcus aureus, Analytical Letters, (2016): 1862-1873
Characterization of Breast Cancer Radiofrequency Ablation Assisted with Magnetic Nanoparticles: In Silico and in Vitro Study. Journal of Electromagnetic Analysis and Applications, 8, 1-7 (2016).
Breast Cancer Tissue Marked Selectively by Magnetic Nanoparticles in an Experimental animal Model”. J. Nanoasci Nanotechnol. (2015),
c-erbB-2 as a Possible Target for the Use of Magnetic Nanoparticles in Breast Cancer Cells”. IEEE Transactions on NanoBioscience (2014), Volume:13, No 3, 300-307.
Impedance spectroscopy assisted by magnetic nanoparticles as a potential biosensor principle for breast cancer cells in suspension”. Physiol Meas (2014) 35 931–941.